Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Clinical Trial
NCT04658472Last updated: 12/4/2025
SAN.PA
Sanofi